About this trial
The purpose of this study is to determine the provider- and practice-level characteristics that influence the impact of implementation strategies guided by practice facilitation in each clinical practice, to test whether the facilitator-driven provider- and practice-level implementation strategies increase provider recommendations and Human Papilloma Virus (HPV) vaccination rates and to evaluate implementation and future sustainability of the facilitator-driven implementation strategies across nine clinical practice sites
Eligibility criteria
Qualifiers
FQHC's with less than 60% HPV vaccine initiation rate for 11-12 year old adolescents overall at their practice sites
FQHC's that have family medicine and/or pediatric practices
a total adolescent patient population at least 50% Latino
be willing for Health Care Provider (HCP) and staff members to receive education, training, and support; complete standardized measurement, and agree to randomization.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Facilitator-driven provider- and practice-level implementation strategies for influencing provider recommendations and practice-level HPV vaccination rates
Treatment groups
Sponsors and collaborators
The University of Texas Health Science Center, Houston
Lead sponsor
National Cancer Institute (NCI)
Collaborator